Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

The MS-LINK Outcomes Study Cohort: Study design and a descriptive analysis of baseline key PROs, disease, and sociodemographic characteristics

Author:English, Jeffrey   Tornatore, Carlo   Riser, Emily   Pardo, Gabriel   Freeman, Leorah   Sloane, Jacob   Piette, Elizabeth   Caon, Christina   Livingston, Terrie   

Session Name:P13: MS Clinical Assessments and Outcome Measures  

Topic:MS and Inflammatory Disease  

Program Number:P13.010  

Author Institution:Multiple Sclerosis Center of Atlanta, Atlanta, GA  MedStar Georgetown University Hospital, Washington, DC  Alabama Neurology Associates, Birmingham, AL  Oklahoma Medical Research Foundation, Oklahoma City, OK  Dell Medical School, The University of Texas at Austin, Austin, TX  Beth Israel Deaconess Medical Center, Boston, MA  EMD Serono, Inc., Rockland, MA  

Fremanezumab for Migraine Prevention: Interim Analysis of the Non-Interventional FINESSE Study

Author:Straube, Andreas   Brössner, Gregor   Gaul, Charly   Hamann, Xenia   Kraya, Torsten   Schauerte, Isabel   Neeb, Lars   

Session Name:P13: Headache: Towards Precision Medicine 3  

Topic:Headache  

Program Number:P13.010  

Author Institution:Ludwig-Maximilians-University Munich, Munich, Germany  Medical University of Innsbruck, Innsbruck, Austria  Headache Center Frankfurt, Frankfurt am Main, Germany  Teva GmbH, Ulm, Germany  St. Georg Hospital/ Headache Center Halle, Leipzig, Germany  Institut Dr. Schauerte, Munich, Germany  Department of Neurology, Charité Universitätsmedizin Berlin/Helios Global Health Berlin